Strengthening Spondyloarthritis Care in the Americas: A Joint Position Statement of the Pan American League of Associations for Rheumatology and the Spondyloarthritis Research and Treatment Network on Education, Collaborative Research, and Mentorship

Spondyloarthritis (SpA) is a leading cause of musculoskeletal morbidity worldwide, disproportionately affecting young individuals in their most productive years.1 Disparities in access, delayed diagnosis (global average of 6.7 years2), and variations in treatment availability remain critical challenges, both globally and particularly across North, Central, and South America.

Authors

Institutions

Publication Details

Journal
The Journal of Rheumatology
Published
2026-10-15
DOI
https://doi.org/10.3899/jrheum.2026-0390
Primary Topic
Spondyloarthritis Studies and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Strengthening Spondyloarthritis Care in the Americas: A Joint Position Statement of the Pan American League of Associations for Rheumatology and the Spondyloarthritis Research and Treatment Network on Education, Collaborative Research, and Mentorship

Fernando Andrés Sommerfleck, Marina Magrey, Carla Gonçalves Schahin Saad, Matthew Laurence Stoll et al.
The Journal of Rheumatology
Spondyloarthritis Studies and Treatments
article

Strengthening Spondyloarthritis Care in the Americas: A Joint Position Statement of the Pan American League of Associations for Rheumatology and the Spondyloarthritis Research and Treatment Network on Education, Collaborative Research, and Mentorship

Fernando Andrés Sommerfleck, Marina Magrey, Carla Gonçalves Schahin Saad, Matthew Laurence Stoll, Carlos Enrique Toro Gutiérrez, Rodrigo Nicolás Garcia Salinas, Rodolfo Pérez-Alamino, Mohamad Nidal Bittar, Antonio Cachafeiro-Vilar, Nigil Haroon, John D. Reveille, Hernán Maldonado Ficco, Sebastián Ibañez, Ignacio García-Valladares, Wilson Bautista‐Molano
article en

Abstract

Spondyloarthritis (SpA) is a leading cause of musculoskeletal morbidity worldwide, disproportionately affecting young individuals in their most productive years.1 Disparities in access, delayed diagnosis (global average of 6.7 years2), and variations in treatment availability remain critical challenges, both globally and particularly across North, Central, and South America.

The Journal of Rheumatology
University Health Network (CA), Universidad del Desarrollo (CL), Oregon Health & Science University (US), Universidad El Bosque (CO), University Hospitals of Cleveland (US), Hospital Punta Pacifica (PA), University of Alabama at Birmingham (US), Hospital Italiano La Plata (AR), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), The University of Texas Health Science Center (US), Case Western Reserve University (US), St. Joseph’s Healthcare Hamilton (CA)
Good health and well-being, Reduced inequalities
Openalex Percentile: Top 12%
Spondyloarthritis Studies and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.